ArticleCancer management and research2019

Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis.

Tomas Buchler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.